|A Note from UH Law Center Dean Ray Nimmer||Vol. 2, No. 2|
It’s with great pride and anticipation for the future that I announce Barbara Evans as the newest member of the Law Center faculty. We will see her throughout the spring semester, and she starts full-time duties in the fall.
Barbara joins our Health Law & Policy Institute, which is widely recognized as one of the nation’s top programs. In this case, the best just got better. Barbara has achieved remarkable things as the director of the Program in Pharmacogenomics, Ethics, and Public Policy at the Indiana University Center for Bioethics. With a Ph.D. from Stanford, a J.D. from Yale Law School and an LL.M. (’03) from our Law Center, she is credited as one of the leaders in her field.
We have big plans for our new professor. I am asking Barbara to join me in leading a new Law Center initiative on biotechnology and the law. In the months ahead, we will create a solid infrastructure to establish the Law Center as a world center for legal scholarship, teaching and expert commentary on biotechnology issues. It’s a fast-paced area of the law, and I believe that our school will play a leading role in defining precisely how our society embraces the remarkable potential of biotechnology.
Achieving our ambitious goal will require time and resources. But this is exactly where we need to be: leveraging our excellence to full effect to make a great law school even better. That’s how our Health Law & Policy Institute grew after health law pioneers at Wood Lucksinger & Epstein and other firms helped start it – and that’s how we will set a standard for excellence in biotechnology and the law.
Please join me in welcoming Barbara Evans to our faculty.
The University of Houston Law Center